AHA GUIDELINES Bundle (free trial)

Hypertrophic Cardiomyopathy 2024

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521559

Contents of this Issue

Navigation

Page 24 of 43

25 7.2. Patient Selection for ICD Placement COR LOE Recommendations 2b B-NR 7. In pediatric patients with HCM, it can be useful to consider additional factors such as extensive LGE on contrast- enhanced CMR imaging and systolic dysfunction in risk stratification for ICD shared decision-making (Figure 3, Table 7). 3: Harm B-NR 8. In patients with HCM without risk factors, ICD placement should not be performed. 3: Harm B-NR 9. In patients with HCM, ICD placement for the sole purpose of participation in competitive athletics should not be performed. (cont'd)

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Hypertrophic Cardiomyopathy 2024